Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Net Sales
341.74
313.14
203.65
Other Operating Income
0.00
0.00
0.00
Total Operating income
341.74
313.14
203.65
Raw Material Cost
79.72
57.60
16.35
Purchase of Finished goods
57.76
58.02
104.68
(Increase) / Decrease In Stocks
-3.37
30.66
-28.01
Employee Cost
40.05
30.27
23.49
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
69.53
66.05
49.13
Total Expenditure (Excl Depreciation)
243.69
242.60
165.64
Operating Profit (PBDIT) excl Other Income
98.05
70.54
38.01
Other Income
5.70
8.83
2.80
Operating Profit (PBDIT)
103.75
79.37
40.81
Interest
19.42
14.91
6.28
Exceptional Items
-0.99
-22.70
0.00
Gross Profit (PBDT)
83.34
41.76
34.53
Depreciation
10.79
7.03
3.93
Profit Before Tax
72.55
34.74
30.60
Tax
16.83
19.06
8.96
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
55.72
15.68
21.64
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
55.72
15.68
21.64
Share in Profit of Associates
0.00
3.53
12.80
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
55.72
19.21
34.45
Equity Capital
16.28
1.58
1.58
Face Value
10.0
10.0
10.0
Reserves
0.00
188.38
160.24
Earnings per share (EPS)
34.23
121.58
218.04
Diluted Earnings per share
34.79
12.2
21.87
Operating Profit Margin (Excl OI)
28.69%
22.53%
18.66%
Gross Profit Margin
24.39%
13.34%
16.96%
PAT Margin
16.3%
5.01%
10.63%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 9.13% vs 53.76% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 190.06% vs -44.24% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 39.00% vs 85.58% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 30.25% vs 137.42% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Q-Line Biotech With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
341.74
310.41
31.33
10.09%
Other Operating Income
0.00
0.00
0.00
Total Operating income
341.74
310.41
31.33
10.09%
Raw Material Cost
79.72
36.48
43.24
118.53%
Purchase of Finished goods
57.76
0.00
57.76
(Increase) / Decrease In Stocks
-3.37
0.00
-3.37
Employee Cost
40.05
53.26
-13.21
-24.80%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
69.53
125.28
-55.75
-44.50%
Total Expenditure (Excl Depreciation)
243.69
215.02
28.67
13.33%
Operating Profit (PBDIT) excl Other Income
98.05
95.39
2.66
2.79%
Other Income
5.70
3.16
2.54
80.38%
Operating Profit (PBDIT)
103.75
98.55
5.20
5.28%
Interest
19.42
12.55
6.87
54.74%
Exceptional Items
-0.99
0.00
-0.99
Gross Profit (PBDT)
83.34
86.00
-2.66
-3.09%
Depreciation
10.79
41.45
-30.66
-73.97%
Profit Before Tax
72.55
44.56
27.99
62.81%
Tax
16.83
13.15
3.68
27.98%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
55.72
31.40
24.32
77.45%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
55.72
31.40
24.32
77.45%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.78
-0.78
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
55.72
32.19
23.53
73.10%
Equity Capital
16.28
10.42
5.86
56.24%
Face Value
10.00
2.00
0.00
Reserves
0.00
234.43
-234.43
-100.00%
Earnings per share (EPS)
34.23
6.18
28.05
453.88%
Diluted Earnings per share
34.79
6.18
28.61
462.94%
Operating Profit Margin (Excl OI)
28.69%
30.73%
0.00
-2.04%
Gross Profit Margin
24.39%
27.71%
0.00
-3.32%
PAT Margin
16.30%
10.12%
0.00
6.18%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 341.74 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 9.13% vs 53.76% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 55.72 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 190.06% vs -44.24% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 98.05 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 39.00% vs 85.58% in Mar 2025
Annual - Interest
Interest 19.42 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 30.25% vs 137.42% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.69%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
